Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.9%

4 terminated out of 102 trials

Success Rate

91.8%

+5.3% vs benchmark

Late-Stage Pipeline

22%

22 trials in Phase 3/4

Results Transparency

4%

2 of 45 completed with results

Key Signals

2 with results92% success

Data Visualizations

Phase Distribution

64Total
Not Applicable (36)
P 1 (3)
P 2 (3)
P 3 (7)
P 4 (15)

Trial Status

Completed45
Unknown31
Recruiting7
Withdrawn6
Terminated4
Enrolling By Invitation3

Trial Success Rate

91.8%

Benchmark: 86.5%

Based on 45 completed trials

Clinical Trials (102)

Showing 20 of 20 trials
NCT06884280Phase 3RecruitingPrimary

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

NCT04603014Phase 2Active Not Recruiting

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients

NCT05449067Not ApplicableCompleted

Nocturnal APD vs. CAPD in Non-diabetic ESKD

NCT04006093Phase 1Completed

Apixaban in Subjects With Peritoneal Dialysis

NCT06641765Not ApplicableActive Not Recruiting

Continuous Glucose Monitoring in Dialysis Patients With Diabetes

NCT06330194Not ApplicableCompleted

Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease

NCT07351357Phase 4Not Yet Recruiting

Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)

NCT04064086Not ApplicableActive Not Recruiting

Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans

NCT07285200CompletedPrimary

Care Burden in Peritoneal Dialysis Caregivers.

NCT07271420Phase 4Recruiting

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

NCT07208513Not Yet RecruitingPrimary

Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis

NCT07098351Not ApplicableRecruiting

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

NCT07131995CompletedPrimary

Formative Usability Testing Study of a Novel Medical Device for Peritoneal Dialysis (WEAKID)

NCT07113574Phase 2Completed

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

NCT07077538Not ApplicableRecruitingPrimary

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

NCT06399848Not ApplicableWithdrawnPrimary

Peritoneal Dialysis Daily Versus Six Days Per Week

NCT04925674Phase 1Completed

Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.

NCT06842927Enrolling By Invitation

Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis

NCT06876987Not ApplicableRecruitingPrimary

The Mobile-based Training System in Peritoneal Dialysis Patients

NCT00397358Phase 4WithdrawnPrimary

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Scroll to load more

Research Network

Activity Timeline